Skip to Content

PGIM Jennison Health Sciences R PJHRX Fund Analysis

| Medalist Rating as of | See PGIM Investment Hub

Morningstar’s Analysis PJHRX

Will PJHRX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Bold, yet appealing.

Senior Analyst Chris Tate

Chris Tate

Senior Analyst

Summary

PGIM Jennison Health Sciences’ deep domain expertise and distinctive approach make for an attractive healthcare offering.

Rated on Published on

Unlock our full analysis with Morningstar Investor